Eroad (ASX: ERD) has become a very popular stock as the Eroad share price rose from $1.40 to $2.56 at the close yesterday.

Persistent seasonal transmissibility may be entrenching itself, as research makes long-term consequences of infection clearer ...

Episode 9 of the ASX Small Cap Wrap covers the following ASX small caps: Siteminder (ASX: SDR) and Audinate (ASX: AD8). Dani ...

Treatment protocol reduced ageing across broad range of physiological symptoms, addressing side effects associated with “stem-cell tourism”.

Generation Development Group Ltd completed two transformative acquisitions in FY 2025, positioning the company for meaningful growth going forward.

Randomized controlled trial in public schools shows 12.5% reduction in student absences in classes with U15 ULPA air purifiers.

Before I (GrowthGauge here) delve into the FY25 results, it is important to understand the history of events for KME. This article marks the anniversary of my coverage of KME stock, shown below. I ...

Over the last couple of weeks, I have received multiple requests for comment on a small speculative radiology software stock called 4D Medical (ASX: 4DX), in part because it announced on July 31, 2025 ...

Now, as bad as it seems, the above result was expected, and the market was well informed about it prior to these results, so I don’t think these numbers drove the share price decline from around $6 ...

I (GrowthGauge) first bought LaserBond (ASX: LBL) on 5 April 2019 at $0.425. The price soon doubled, then sank to $0.28 in the COVID crash. It climbed to almost $1.00 in 2021 and has drifted since.